[Clinical application research of feilinjian peroral liquid in the treatment of Chlamydia and Mycoplasma infectious prostatitis].
OBJECTIVE
To evaluate the validity and security of Feilinjian peroral liquid in the treatment of chlamydia trachomatis (CT), mycoplasma hominis (Mh) and Ureaplasma urealyticum (UU) infectious prostatitis.


METHODS
Two hundred and three patients of CT, Mh or UU infectious prostatitis diagnosed by strict orientation examination were randomly divided into two groups, one given feilinjian peroral liquid, and the other azithromycin perorally, for one month as treatment period.


RESULTS
The analytical results showed that 54 (42.86%) were clinically fully recovered, 32(32.39%) were significantly effective, and 13 (10.31%) were effective in feilinjian peroral liquid group, with total significantly effective rate 68.25% and total effective rate 78.57%, both obviously higher than those in the control group(50.64% and 57.14% respectively).


CONCLUSIONS
Feilinjian peroral liquid is significantly better than azithromycin in ameliorating self-conscious symptoms, symptoms scoring of patients with CT, Mh and UU infection, with little side-effects.
Jiang
Yi
Y
Department of Andrology, General Hospital, Panzhihua Steel & Iron (Group) Co., Panzhihua, Sichuan 617023, China.
Wang
Jiu-Yuan
JY
Zhang
Shu-Wu
SW
D000328:Adult; D002690:Chlamydia Infections / Q000188:drug therapy*; D002692:Chlamydia trachomatis; D004365:Drugs, Chinese Herbal / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D008875:Middle Aged; D019535:Mycoplasma hominis; D009180:Mycoplasmatales Infections / Q000188:drug therapy*; D008517:Phytotherapy; D011472:Prostatitis / Q000188:drug therapy* / Q000382:microbiology; D016990:Ureaplasma urealyticum
D004365:Drugs, Chinese Herbal